Vaccines against cervical cancer provoke US controversy

Vaccines against cervical cancer provoke US controversy.

Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical Cancers

Cervical cancer is, globally known to be, one of the most common cancers among women especially indeveloping countries. More than 90% of cervical cancers are associated with high-risk humanpapillomaviruses (HPVs) particularly HPV types 16 and 18. Two major strategies have been developed forprevention and treatment of cervical cancer and other HPV-associated malignancies; the first one is based ...

Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer

Cervical cancer and its precursor intra-epithelial lesions are linked to infection by a subset of so-called "highrisk" human papillomavirus types, which are estimated to infect nearly four hundred million women worldwide. Two prophylactic vaccines have been commercialized recently targeting HPV16 and 18, the most prevalent viral types found in cervical cancer, which operate through induction of...

Vaccines for cervical cancer.

The review focuses on current and future prevention of invasive cervical cancer (ICC), the second most common cancer among women worldwide. Implementation of population-based cytological screening programmes, using the 'Pap' smear to detect pre-cancerous lesions in the cervix, has resulted in substantial declines in mortality and morbidity from ICC in North America and some European countries. ...

HPV vaccines and cervical cancer.

Human papillomavirus (HPV) vaccines have opened a new perspective on the prevention of cervical cancer, one of the most paradigmatic long-term goals of the cancer prevention field. For decades, prevention has been and still is partially fulfilled by the expansion of the practice of cervical cytology (the Pap smear) repeated frequently in tens of millions of asymptomatic women worldwide. The pra...